Revenue, last quarter
$17.1K
−83.9% vs same quarter last year
Net income
−$2.9M
−20.9% vs same quarter last year
EPS, diluted
−$1.28
+99.5% vs same quarter last year
Operating cash flow
−$1.9M
−36% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $815.4K | −$14M |
| FY24 | $2.5M | −$58.7M |
| FY23 | $58.5K | −$37.4M |
| FY22 | - | −$13.4M |
| FY21 | - | −$3.4M |
| FY20 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 77.6% | −2190% | −1721% |
| FY24 | 41.8% | −2238% | −2325.2% |
| FY23 | −1927.9% | −61634.5% | −63986.5% |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$10.5M |
| FY23 | −$13.6M |
| FY22 | −$8.7M |
| FY21 | −$2M |
| FY20 | - |
- Onconetix
- Healthcare median
Show the numbers
| Year | Onconetix | Healthcare median |
|---|---|---|
| FY25 | −1721% | −66.4% |
| FY24 | −2325.2% | −87% |
| FY23 | −63986.5% | −128.5% |
| FY22 | - | −143.6% |
| FY21 | - | −137.7% |
| FY20 | - | −134.3% |
News
No stories filed under Onconetix yet - coverage appears here as the news feed clusters it.